Truvestments Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.49M | Sell |
26,568
-3,799
| -13% | -$885K | 1.17% | 11 |
|
|
2025
Q4 | $6.28M | Sell |
30,367
-845
| -3% | -$167K | 1.14% | 12 |
|
|
2025
Q3 | $5.79M | Sell |
31,212
-4,166
| -12% | -$714K | 1.05% | 14 |
|
|
2025
Q2 | $5.4M | Sell |
35,378
-1,367
| -4% | -$210K | 1.08% | 10 |
|
|
2025
Q1 | $6.09M | Buy |
36,745
+10,296
| +39% | +$1.61M | 1.32% | 9 |
|
|
2024
Q4 | $3.83M | Buy |
26,449
+1,144
| +5% | +$177K | 0.98% | 17 |
|
|
2024
Q3 | $4.1M | Buy |
25,305
+2,849
| +13% | +$454K | 1.1% | 12 |
|
|
2024
Q2 | $3.28M | Buy |
22,456
+651
| +3% | +$96.8K | 1.31% | 14 |
|
|
2024
Q1 | $3.45M | Buy |
21,805
+1,690
| +8% | +$269K | 1.33% | 13 |
|
|
2023
Q4 | $3.15M | Buy |
20,115
+195
| +1% | +$29.9K | 1.42% | 11 |
|
|
2023
Q3 | $3.1M | Buy |
19,920
+406
| +2% | +$67K | 1.62% | 9 |
|
|
2023
Q2 | $3.23M | Buy |
19,514
+630
| +3% | +$102K | 1.61% | 9 |
|
|
2023
Q1 | $2.93M | Buy |
18,884
+263
| +1% | +$42.5K | 1.56% | 7 |
|
|
2022
Q4 | $3.29M | Sell |
18,621
-1,910
| -9% | -$330K | 1.86% | 5 |
|
|
2022
Q3 | $3.35M | Buy |
20,531
+786
| +4% | +$133K | 2.12% | 6 |
|
|
2022
Q2 | $3.5M | Buy |
19,745
+354
| +2% | +$63.1K | 2.05% | 6 |
|
|
2022
Q1 | $3.44M | Buy |
19,391
+306
| +2% | +$52.1K | 1.88% | 10 |
|
|
2021
Q4 | $3.27M | Buy |
19,085
+199
| +1% | +$32.6K | 1.64% | 9 |
|
|
2021
Q3 | $3.05M | Buy |
18,886
+595
| +3% | +$102K | 1.68% | 8 |
|
|
2021
Q2 | $3.01M | Buy |
18,291
+97
| +0.5% | +$16.1K | 1.65% | 7 |
|
|
2021
Q1 | $2.99M | Buy |
18,194
+2,260
| +14% | +$366K | 1.69% | 8 |
|
|
2020
Q4 | $2.51M | Buy |
15,934
+499
| +3% | +$73.6K | 1.74% | 6 |
|
|
2020
Q3 | $2.3M | Sell |
15,435
-1,532
| -9% | -$227K | 2.08% | 7 |
|
|
2020
Q2 | $2.38M | Buy |
16,967
+1,867
| +12% | +$272K | 2.43% | 6 |
|
|
2020
Q1 | $1.98M | Sell |
15,100
-7,170
| -32% | -$1.02M | 2.52% | 5 |
|
|
2019
Q4 | $3.25M | Sell |
22,270
-30
| -0.1% | -$4.07K | 2.25% | 5 |
|
|
2019
Q3 | $2.88M | Buy |
22,300
+880
| +4% | +$116K | 1.88% | 7 |
|
|
2019
Q2 | $2.98M | Buy |
21,420
+2,750
| +15% | +$381K | 2.01% | 6 |
|
|
2019
Q1 | $2.61M | Buy |
+18,670
| New | +$2.5M | 2% | 11 |
|
|
2018
Q3 | $3.16M | Buy |
22,885
+1,400
| +7% | +$186K | 1.52% | 12 |
|
|
2018
Q2 | $2.61M | Buy |
+21,485
| New | +$2.68M | 1.64% | 12 |
|
Other funds holding JNJ
VCM
VPM
Truvestments Capital's JNJ Position: Q1 2026 in Review
Truvestments Capital reduced its Johnson & Johnson (JNJ) stake by 13% in Q1 2026, selling an estimated $885K and leaving 26,568 shares worth $6.49M. The position accounts for 1.17% of the portfolio, ranked #11.
Truvestments Capital first reported a position in JNJ in Q2 2018 and has held it in 31 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Truvestments Capital held 26,568 shares of Johnson & Johnson worth $6.49M as of Q1 2026.
- Truvestments Capital sold 3,799 Johnson & Johnson shares in Q1 2026, an estimated $885K.
- Johnson & Johnson made up 1.17% of Truvestments Capital's portfolio in Q1 2026, its #11 holding.
- Truvestments Capital first reported a position in Johnson & Johnson in Q2 2018 and has held it in 31 quarters since.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.